Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAPK1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | ATXN7L3B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | THEGL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | ZNF260 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | TMEM178B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | MOSPD2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | RUNDC3B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | PLCB2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | KDM3B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |